Morag Park CQ FRSC is a breast cancer and genomics researcher at the McGill University Health Centre. [1] Park is known for her work on the combination of genetic and epigenetic alterations that result in breast cancer progression and receptor tyrosine kinases involved in cancer. [2] More recently, she has worked in as primary co-researcher of a Quebec cancer biobank network that creates tumor models derived from patients, allowing for research into why individual patients respond well or poorly to cancer therapies. [3] She is currently a professor in the Gerald Bronfman Department of Oncology and a member of the Faculty of Medicine and Health Sciences at McGill University. [1]
Park conducted her undergraduate studies at University of Glasgow and received a B.Sc. with first class honors. She received a PhD in viral carcinogenesis at the Medical Research Council Virology Institute in Scotland and conducted her post-doctoral research at the National Institutes for Cancer Research in Washington, DC. [4]
2022 Woman of Distinction Award in Research and Innovation [3] [5]
Club de Recherches Cliniques du Québec Michel Sarrazin Award (2021) [6]
Quebec Breast Cancer Foundation Grand Prix Scientifique (2019) [5]
Canadian Cancer Society 2017 Robert L. Noble Prize [7]
2015 Canadian Cancer Research Alliance Award for Exceptional Leadership in Cancer Research [8]
Morag Park CQ FRSC is a breast cancer and genomics researcher at the McGill University Health Centre. [1] Park is known for her work on the combination of genetic and epigenetic alterations that result in breast cancer progression and receptor tyrosine kinases involved in cancer. [2] More recently, she has worked in as primary co-researcher of a Quebec cancer biobank network that creates tumor models derived from patients, allowing for research into why individual patients respond well or poorly to cancer therapies. [3] She is currently a professor in the Gerald Bronfman Department of Oncology and a member of the Faculty of Medicine and Health Sciences at McGill University. [1]
Park conducted her undergraduate studies at University of Glasgow and received a B.Sc. with first class honors. She received a PhD in viral carcinogenesis at the Medical Research Council Virology Institute in Scotland and conducted her post-doctoral research at the National Institutes for Cancer Research in Washington, DC. [4]
2022 Woman of Distinction Award in Research and Innovation [3] [5]
Club de Recherches Cliniques du Québec Michel Sarrazin Award (2021) [6]
Quebec Breast Cancer Foundation Grand Prix Scientifique (2019) [5]
Canadian Cancer Society 2017 Robert L. Noble Prize [7]
2015 Canadian Cancer Research Alliance Award for Exceptional Leadership in Cancer Research [8]